Literature DB >> 33215946

The role of cytochrome P450 (CYP) enzymes in hyperoxic lung injury.

Rachel Stading1, Xanthi Couroucli1, Krithika Lingappan1, Bhagavatula Moorthy1.   

Abstract

INTRODUCTION: Hyperoxic lung injury is a condition that can occur in patients in need of supplemental oxygen, such as premature infants with bronchopulmonary dysplasia or adults with acute respiratory distress syndrome. Cytochrome P450 (CYP) enzymes play critical roles in the metabolism of endogenous and exogenous compounds. AREAS COVERED: Through their complex pathways, some subfamilies of these enzymes may contribute to or protect against hyperoxic lung injury. Oxidative stress from reactive oxygen species (ROS) production is most likely a major contributor of hyperoxic lung injury. CYP1A enzymes have been shown to protect against hyperoxic lung injury while CYP1B enzymes seem to contribute to it. CYP2J2 enzymes help protect against hyperoxic lung injury by triggering EET production, thereby, increasing antioxidant enzymes. The metabolism of arachidonic acid to ω-terminal hydroxyeicosatetraenoic acid (20-HETEs) by CYP4A and CYP4F enzymes could impact hyperoxic lung injury via the vasodilating effects of 20-HETE. CYP2E1 and CYP2A enzymes may contribute to the oxidative stress in the lungs caused by ethanol- and nicotine-metabolism, respectively. EXPERT OPINION: Overall, the CYP enzymes, depending upon the isoform, play a contributory or protective role in hyperoxic lung injury, and are, therefore, ideal candidates for developing drugs that can treat oxygen-mediated lung injury.

Entities:  

Keywords:  CYP1A enzyme; CYP1B enzyme; CYP2A enzyme; CYP2E1 enzyme; CYP2J2 enzyme; CYP4A enzyme; CYP4F enzyme; cytochrome P450 (CYP) enzymes; hyperoxic lung injury; oxidative stress

Mesh:

Substances:

Year:  2020        PMID: 33215946      PMCID: PMC7864879          DOI: 10.1080/17425255.2021.1853705

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  87 in total

1.  CYP2A13: variable expression and role in human lung microsomal metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  Xiuling Zhang; Jaime D'Agostino; Hong Wu; Qing-Yu Zhang; Linda von Weymarn; Sharon E Murphy; Xinxin Ding
Journal:  J Pharmacol Exp Ther       Date:  2007-08-01       Impact factor: 4.030

2.  Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues.

Authors:  Dharamainder Choudhary; Ingela Jansson; Ivaylo Stoilov; Mansoor Sarfarazi; John B Schenkman
Journal:  Arch Biochem Biophys       Date:  2005-04-01       Impact factor: 4.013

Review 3.  Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity.

Authors:  F P Guengerich
Journal:  Chem Res Toxicol       Date:  2001-06       Impact factor: 3.739

4.  Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  T Su; Z Bao; Q Y Zhang; T J Smith; J Y Hong; X Ding
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

5.  Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. Cloning, sequence determination, and tissue expression.

Authors:  U Savas; K K Bhattacharyya; M Christou; D L Alexander; C R Jefcoate
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

Review 6.  Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1.

Authors:  Tsutomu Shimada; Yoshiaki Fujii-Kuriyama
Journal:  Cancer Sci       Date:  2004-01       Impact factor: 6.716

Review 7.  The role of CYP2E1 in alcohol metabolism and sensitivity in the central nervous system.

Authors:  Claire Heit; Hongbin Dong; Ying Chen; David C Thompson; Richard A Deitrich; Vasilis K Vasiliou
Journal:  Subcell Biochem       Date:  2013

8.  CYP4Fs expression in rat brain correlates with changes in LTB4 levels after traumatic brain injury.

Authors:  Ying Wang; Jing Zhao; Auinash Kalsotra; Cheri M Turman; Raymond J Grill; Pramod K Dash; Henry W Strobel
Journal:  J Neurotrauma       Date:  2008-10       Impact factor: 5.269

9.  Mice Lacking the Cytochrome P450 1B1 Gene Are Less Susceptible to Hyperoxic Lung Injury Than Wild Type.

Authors:  Alex C Veith; Boura'a Bou Aram; Weiwu Jiang; Lihua Wang; Guodong Zhou; Colin R Jefcoate; Xanthi I Couroucli; Krithika Lingappan; Bhagavatula Moorthy
Journal:  Toxicol Sci       Date:  2018-10-01       Impact factor: 4.849

10.  Deletion of soluble epoxide hydrolase attenuates mice Hyperoxic acute lung injury.

Authors:  Li-Ping Liu; Bin Li; Tian-Kui Shuai; Lei Zhu; Yu-Min Li
Journal:  BMC Anesthesiol       Date:  2018-04-27       Impact factor: 2.217

View more
  4 in total

1.  The Effectiveness of Dietary Byproduct Antioxidants on Induced CYP Genes Expression and Histological Alteration in Piglets Liver and Kidney Fed with Aflatoxin B1 and Ochratoxin A.

Authors:  Roua Gabriela Popescu; Cristina Bulgaru; Arabela Untea; Mihaela Vlassa; Miuta Filip; Anca Hermenean; Daniela Marin; Ionelia Țăranu; Sergiu Emil Georgescu; Anca Dinischiotu
Journal:  Toxins (Basel)       Date:  2021-02-15       Impact factor: 4.546

2.  Effects of Real-Ambient PM2.5 Exposure on Lung Damage Modulated by Nrf2-/.

Authors:  Hao Ding; Menghui Jiang; Daochuan Li; Yanjie Zhao; Dianke Yu; Rong Zhang; Wen Chen; Jingbo Pi; Rui Chen; Lianhua Cui; Yuxin Zheng; Jinmei Piao
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

Review 3.  The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy.

Authors:  Guyi Wang; Bing Xiao; Jiayi Deng; Linmei Gong; Yi Li; Jinxiu Li; Yanjun Zhong
Journal:  Front Pharmacol       Date:  2022-02-02       Impact factor: 5.810

4.  Role of Human NADPH Quinone Oxidoreductase (NQO1) in Oxygen-Mediated Cellular Injury and Oxidative DNA Damage in Human Pulmonary Cells.

Authors:  Rebecca Burke; Chun Chu; Guo-Dong Zhou; Vasanta Putluri; Nagireddy Putluri; Rachel E Stading; Xanthi Couroucli; Krithika Lingappan; Bhagavatula Moorthy
Journal:  Oxid Med Cell Longev       Date:  2021-10-15       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.